Quick Answer
Yubo International Biotech Ltd reported Stockholders Equity of -$1.95 million for fiscal year 2025.
Yubo International Biotech Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$1.95M | +42.9% |
| 2024 | -$3.42M | -85.7% |
| 2023 | -$1.84M | -226.1% |
| 2022 | -$565.4K | -330.9% |
| 2021 | -$131.2K | -111.2% |
| 2020 | $1.17M | +164.9% |
| 2020 | -$1.80M | -467.9% |
| 2019 | $488.7K | +129.4% |
| 2019 | -$1.66M | -9.8% |
| 2018 | -$1.52M | -10.5% |
| 2017 | -$1.37M | -9.1% |
| 2016 | -$1.26M | -11.5% |
| 2015 | -$1.13M | -11.5% |
| 2014 | -$1.01M | -11.7% |
| 2013 | -$906.0K | -12.8% |
| 2012 | -$803.0K | -11.7% |
| 2011 | -$719.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.66M | +46.9% | +58.4% |
| June 30, 2025 | -$4.00M | -58.5% | -9.0% |
| March 31, 2025 | -$3.67M | -77.6% | -7.2% |
| December 31, 2024 | -$3.42M | -85.7% | -9.4% |
| September 30, 2024 | -$3.13M | -184.4% | -24.0% |
| June 30, 2024 | -$2.52M | -119.3% | -22.1% |
| March 31, 2024 | -$2.07M | -146.3% | -12.1% |
| December 31, 2023 | -$1.84M | -226.1% | -67.5% |
- Yubo International Biotech Ltd showed an increase of +42.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Yubo International Biotech Ltd’s stockholders equity has declined by 171.9% (from -$719.0 thousand to -$1.95 million).
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: